Skip to main content
Erschienen in: Osteoporosis International 7/2012

01.07.2012 | Original Article

SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions

verfasst von: J. C. Davis, T. Liu-Ambrose, K. M. Khan, M. C. Robertson, C. A. Marra

Erschienen in: Osteoporosis International | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Summary

Using two instruments (SF-6D and EQ-5D) to estimate quality adjusted life years (QALYs), we conducted an economic evaluation of a 12-month randomized controlled trial with a 12-month follow-up study in older women to evaluate the value for money of two doses of resistance training compared with balance and tone classes. We found that the incremental QALYs estimated from the SF-6D were two- to threefold greater than those estimated from the EQ-5D.

Introduction

Decision makers must continually choose between existing and new interventions. Hence, economic evaluations are increasingly prevalent. The impact of quality-adjusted life year (QALY) estimates using different instruments on the incremental cost-effectiveness ratios (ICERs) is not well understood in older adults. Thus, we compared ICERs, in older women, estimated by the EuroQol-5D (EQ-5D) and the Short Form-6D (SF-6D) to discuss implications on decision making.

Methods

Using both the EQ-5D and the SF-6D, we compared the incremental cost per QALY gained in a randomized controlled trial of resistance training in 155 community-dwelling women aged 65 to 75 years. The 12-month randomized controlled trial included a subsequent 12-month follow-up. Our focus, the follow-up study, included 123 of the 155 participants from the Brain Power study; 98 took part in the economic evaluation (twice-weekly balance and tone exercises, n = 28; once-weekly resistance training, n = 35; twice-weekly resistance training, n = 35). Our primary outcome measure was the incremental cost per QALY gained of once- or twice-weekly resistance training compared with balance and tone exercises.

Results

At cessation of the follow-up study, the incremental QALY was −0.051 (EQ-5D) and −0.144 (SF-6D) for the once-weekly resistance training group and −0.081 (EQ-5D) and −0.127 (SF-6D) for the twice-weekly resistance training group compared with balance and tone classes.

Conclusion

The incremental QALYs estimated from the SF-6D were two- to threefold greater than those estimated from the EQ-5D. Given the large magnitude of difference, the choice of preference-based utility instrument may substantially impact health care decisions.
Literatur
1.
Zurück zum Zitat Claxton K, Sculpher M, Drummond M (2002) A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet 360:711–715PubMedCrossRef Claxton K, Sculpher M, Drummond M (2002) A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet 360:711–715PubMedCrossRef
2.
Zurück zum Zitat Fenwick E, Marshall DA, Blackhouse G, Vidaillet H, Slee A, Shemanski L, Levy AR (2008) Assessing the impact of censoring of costs and effects on health-care decision-making: an example using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Value Health 11:365–375PubMedCrossRef Fenwick E, Marshall DA, Blackhouse G, Vidaillet H, Slee A, Shemanski L, Levy AR (2008) Assessing the impact of censoring of costs and effects on health-care decision-making: an example using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Value Health 11:365–375PubMedCrossRef
3.
Zurück zum Zitat Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB (2005) Growth and quality of the cost-utility literature, 1976–2001. Value Health 8:3–9PubMedCrossRef Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB (2005) Growth and quality of the cost-utility literature, 1976–2001. Value Health 8:3–9PubMedCrossRef
4.
Zurück zum Zitat Siegel JE, Weinstein MC, Russell LB, Gold MR (1996) Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 276:1339–1341PubMedCrossRef Siegel JE, Weinstein MC, Russell LB, Gold MR (1996) Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 276:1339–1341PubMedCrossRef
5.
Zurück zum Zitat Brazier J, Roberts J, Tsuchiya A, Busschbach J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873–884PubMedCrossRef Brazier J, Roberts J, Tsuchiya A, Busschbach J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873–884PubMedCrossRef
6.
Zurück zum Zitat Tsuchiya A, Brazier J, Roberts J (2006) Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ 25:334–346PubMedCrossRef Tsuchiya A, Brazier J, Roberts J (2006) Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ 25:334–346PubMedCrossRef
7.
Zurück zum Zitat Neumann PJ, Goldie SJ, Weinstein MC (2000) Preference-based measures in economic evaluation in health care. Annu Rev Public Health 21:587–611PubMedCrossRef Neumann PJ, Goldie SJ, Weinstein MC (2000) Preference-based measures in economic evaluation in health care. Annu Rev Public Health 21:587–611PubMedCrossRef
8.
Zurück zum Zitat McDonough CM, Tosteson AN (2007) Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics 25:93–106PubMedCrossRef McDonough CM, Tosteson AN (2007) Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics 25:93–106PubMedCrossRef
9.
Zurück zum Zitat Sach TH, Barton GR, Jenkinson C, Doherty M, Avery AJ, Muir KR (2009) Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter? Med Care 47:889–894PubMedCrossRef Sach TH, Barton GR, Jenkinson C, Doherty M, Avery AJ, Muir KR (2009) Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter? Med Care 47:889–894PubMedCrossRef
11.
Zurück zum Zitat Dolan P, Roberts J (2002) Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care 40:442–446PubMedCrossRef Dolan P, Roberts J (2002) Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care 40:442–446PubMedCrossRef
12.
Zurück zum Zitat Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292PubMedCrossRef Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292PubMedCrossRef
13.
Zurück zum Zitat Brazier J, Usherwood T, Harper R, Thomas K (1998) Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 51:1115–1128PubMedCrossRef Brazier J, Usherwood T, Harper R, Thomas K (1998) Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 51:1115–1128PubMedCrossRef
14.
Zurück zum Zitat Joore M, Brunenberg D, Nelemans P, Wouters E, Kuijpers P, Honig A, Willems D, de Leeuw P, Severens J, Boonen A (2011) The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies. Value Health 13:222–229CrossRef Joore M, Brunenberg D, Nelemans P, Wouters E, Kuijpers P, Honig A, Willems D, de Leeuw P, Severens J, Boonen A (2011) The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies. Value Health 13:222–229CrossRef
15.
Zurück zum Zitat Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60:1571–1582PubMedCrossRef Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60:1571–1582PubMedCrossRef
16.
Zurück zum Zitat Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC (2010) Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med 170:170–178PubMedCrossRef Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC (2010) Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med 170:170–178PubMedCrossRef
17.
Zurück zum Zitat Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T (2010) Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporos Int 22:1355–1366PubMedCrossRef Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T (2010) Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporos Int 22:1355–1366PubMedCrossRef
18.
Zurück zum Zitat Davis JC, Marra CA, Beattie BL, Robertson MC, Najafzadeh M, Graf P, Nagamatsu LS, Liu-Ambrose T (2010) Sustained cognitive and economic benefits of resistance training among community-dwelling senior women: a 1-year follow-up study of the Brain Power study. Arch Intern Med 170:2036–2038PubMedCrossRef Davis JC, Marra CA, Beattie BL, Robertson MC, Najafzadeh M, Graf P, Nagamatsu LS, Liu-Ambrose T (2010) Sustained cognitive and economic benefits of resistance training among community-dwelling senior women: a 1-year follow-up study of the Brain Power study. Arch Intern Med 170:2036–2038PubMedCrossRef
19.
Zurück zum Zitat Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C (2004) The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 63:395–401PubMedCrossRef Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C (2004) The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 63:395–401PubMedCrossRef
20.
Zurück zum Zitat Liu-Ambrose T, Ashe MC, Marra C, Conditions Research Team PA (2008) Among older adults with multiple chronic conditions, physical activity is independently and inversely associated with health care utilization. Br J Sports Med 44(14):1024–1028PubMedCrossRef Liu-Ambrose T, Ashe MC, Marra C, Conditions Research Team PA (2008) Among older adults with multiple chronic conditions, physical activity is independently and inversely associated with health care utilization. Br J Sports Med 44(14):1024–1028PubMedCrossRef
22.
23.
Zurück zum Zitat Manca A, Hawkins N, Sculpher MJ (2005) Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 14:487–496PubMedCrossRef Manca A, Hawkins N, Sculpher MJ (2005) Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 14:487–496PubMedCrossRef
24.
Zurück zum Zitat Manca A, Palmer S (2005) Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Appl Health Econ Health Policy 4:65–75PubMedCrossRef Manca A, Palmer S (2005) Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Appl Health Econ Health Policy 4:65–75PubMedCrossRef
25.
Zurück zum Zitat Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300:230–235PubMedCrossRef Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300:230–235PubMedCrossRef
26.
Zurück zum Zitat Briggs AH, Gray AM (1999) Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 3:1–134PubMed Briggs AH, Gray AM (1999) Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 3:1–134PubMed
27.
Zurück zum Zitat Fenwick E, Claxton K, Sculpher M (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 10:779–787PubMedCrossRef Fenwick E, Claxton K, Sculpher M (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 10:779–787PubMedCrossRef
28.
Zurück zum Zitat Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T (2011) Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporos Int 22:1355–1366PubMedCrossRef Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T (2011) Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporos Int 22:1355–1366PubMedCrossRef
29.
Zurück zum Zitat Barton GR, Sach TH, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR (2008) A comparison of the performance of the EQ-5D and SF-6D for individuals aged > or =45 years. Health Econ 17:815–832PubMedCrossRef Barton GR, Sach TH, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR (2008) A comparison of the performance of the EQ-5D and SF-6D for individuals aged > or =45 years. Health Econ 17:815–832PubMedCrossRef
30.
Zurück zum Zitat Bharmal M, Thomas J 3rd (2006) Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9:262–271PubMedCrossRef Bharmal M, Thomas J 3rd (2006) Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9:262–271PubMedCrossRef
31.
Zurück zum Zitat Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL (2005) Methods for the economic evaluation for health care programmes, Thirdth edn. Oxford University Press, New York Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL (2005) Methods for the economic evaluation for health care programmes, Thirdth edn. Oxford University Press, New York
32.
Zurück zum Zitat Conner-Spady B, Suarez-Almazor ME (2003) Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care 41:791–801PubMedCrossRef Conner-Spady B, Suarez-Almazor ME (2003) Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care 41:791–801PubMedCrossRef
33.
Zurück zum Zitat Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A, Anis AH (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care 42:1125–1131PubMedCrossRef Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A, Anis AH (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care 42:1125–1131PubMedCrossRef
34.
Zurück zum Zitat Pickard AS, Johnson JA, Feeny DH (2005) Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 14:207–219PubMedCrossRef Pickard AS, Johnson JA, Feeny DH (2005) Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 14:207–219PubMedCrossRef
35.
Zurück zum Zitat Marra CA, Marion SA, Guh DP, Najafzadeh M, Wolfe F, Esdaile JM, Clarke AE, Gignac MA, Anis AH (2007) Not all “quality-adjusted life years” are equal. J Clin Epidemiol 60:616–624PubMedCrossRef Marra CA, Marion SA, Guh DP, Najafzadeh M, Wolfe F, Esdaile JM, Clarke AE, Gignac MA, Anis AH (2007) Not all “quality-adjusted life years” are equal. J Clin Epidemiol 60:616–624PubMedCrossRef
36.
Zurück zum Zitat Pignone M, Earnshaw S, Pletcher MJ, Tice JA (2007) Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med 167:290–295PubMedCrossRef Pignone M, Earnshaw S, Pletcher MJ, Tice JA (2007) Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med 167:290–295PubMedCrossRef
Metadaten
Titel
SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions
verfasst von
J. C. Davis
T. Liu-Ambrose
K. M. Khan
M. C. Robertson
C. A. Marra
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 7/2012
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-011-1770-3

Weitere Artikel der Ausgabe 7/2012

Osteoporosis International 7/2012 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.